NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/09/2024
Back to search
Official data from USPTO
DRUG CO DISCOUNT PHARMACIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
07/09/2024
Trademark type
Combined
Nice classes
35
Filing date
04/01/2022
Registration date
07/09/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/09/2024
Last transaction
07/09/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
12/31/1988
First use in commerce
12/31/1988
Drawing code
3
Owner type
03
Owner location
Roanoke Rapids, NC, US
Examiner
CHANG, BETTY
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "DRUGCO" above the words "DISCOUNT PHARMACIES." The "R" in "DRUGCO" has a line going through it forming an "X." There is a double line between "DRUGCO" and "DISCOUNT PHARMACIES".
Holders and representatives
Holders
DDP Pharmacy, Inc.
Representatives
ASHLEY D JOHNSON DOGWOOD PATENT AND TRADEMARK LAW
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Mail order pharmacy services; Pharmaceutical servicesprocessing online and telephone prescription orders in retail and central fill pharmacies; Retail pharmacy services; Specialized retail pharmacy services for patients with particular medical conditions
Publications
History of USPTO decisions and trademark events.
34 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/23/2024
PUBO
PUBLISHED FOR OPPOSITION
04/23/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/17/2024
EXPT
EXPARTE APPEAL TERMINATED
03/15/2024
EXDA
EXPARTE APPEAL DISCLAIMER ACCEPTED
03/15/2024
EXPA
EX PARTE APPEAL-REFUSAL AFFIRMED
02/27/2024
GNSN
NOTIFICATION OF EXAMINERS STATEMENT E-MAILED
10/12/2023
GNES
EXAMINERS STATEMENT E-MAILED
10/12/2023
CNES
EXAMINERS STATEMENT - COMPLETED
10/12/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
08/24/2023
GEA1
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
07/05/2023
GECD
ACTION DENYING REQ FOR RECON E-MAILED
07/05/2023
CNCF
ACTION CONTINUING FINAL - COMPLETED
07/05/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
06/12/2023
EXPI
EX PARTE APPEAL-INSTITUTED
06/12/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
06/12/2023
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
06/12/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
03/10/2023
GNFR
FINAL REFUSAL E-MAILED
03/10/2023
CNFR
FINAL REFUSAL WRITTEN
03/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/09/2023
DOCK
ASSIGNED TO EXAMINER
02/22/2023
GPRN
NOTIFICATION OF PRIORITY ACTION E-MAILED
01/31/2023
GPRA
PRIORITY ACTION E-MAILED
01/31/2023
CPRA
PRIORITY ACTION WRITTEN
01/31/2023
DOCK
ASSIGNED TO EXAMINER
01/18/2023
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
04/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/06/2022
NWAP
NEW APPLICATION ENTERED
04/05/2022
Continuous trademark protection
Get notified about every new filing that threatens DRUG CO DISCOUNT PHARMACIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.